Commentary: Nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate name-Reference-Cited by-同舟云学术

Commentary: Nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate name

Published:2020-12 Issue: Volume:113 Page:154413
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Polyzos Stergios A.,Kang Eun Seok,Tsochatzis Emmanuel A.,Kechagias Stergios,Ekstedt Mattias,Xanthakos Stavra,Lonardo Amedeo,Mantovani Alessandro,Tilg Herbert,Côté Isabelle,Grefhorst Aldo,Greene Michael W.,Araujo-Vilar David,Alisi Anna,Casanueva Felipe,Mantzoros Christos S.

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference6 articles.

1. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis;Diehl;N Engl J Med,2017

2. Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis;Polyzos;Metabolism,2020

3. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease;Eslam;Gastroenterology,2020

4. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement;Eslam;J Hepatol,2020

5. Comparison of MAFLD and NAFLD diagnostic criteria in real world;Lin;Liver Int,2020

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic dysfunction-associated steatotic liver disease: Recent turning points for its diagnosis and management;Metabolism;2024-08

2. Potential of Chlorogenic Acid in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Animal Studies and Clinical Trials—A Narrative Review;Metabolites;2024-06-20

3. Metabolic disorders induced the changes in the expressions of TNFα, E-cadherin and ultrastructural alteration of liver cells in a typical animal model of type 2 diabetes: Psammomys obesus;Tissue and Cell;2024-06

4. Circulating Ferritin in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis;Journal of Clinical and Experimental Hepatology;2024-05

5. Partial validation of a six-month high-fat diet and fructose-glucose drink combination as a mouse model of nonalcoholic fatty liver disease;Endocrine;2024-03-20